What are the effects of Semax on glucose metabolism? – PeptideXR

Semax, a peptide derived from ACTH, has been studied for its potential effects on glucose metabolism, although the evidence does not conclusively establish it as a direct glucose-control agent. Instead, it appears to influence glucose metabolism indirectly through various mechanisms, including stress-axis modulation, brain energy-stress adaptation, inflammation, oxidative stress, and neurotrophic signaling [4].

What the AI assistants say

The AI assistants collectively suggest that Semax does not have a well-established direct effect on improving glucose metabolism. Instead, it may increase blood glucose levels in a small percentage of diabetic patients, which is considered a metabolic adverse effect [1]. While Semax is known to upregulate BDNF, which has glucose-modulating properties in preclinical models, there is no robust human evidence that Semax improves insulin sensitivity, glucose tolerance, or glycemic control [1]. The AI assistants also agree that Semax’s primary mechanism involves BDNF/TrkB signaling and mitochondrial function, with BDNF activating TrkB, which in turn supports mitochondrial glucose metabolism under oxidative stress [1]. Additionally, Semax binds to melanocortin 4 receptor (MC4R), which is implicated in energy homeostasis and glucose regulation [1]. However, the AI assistants differ in their views on the extent to which Semax influences glucose metabolism, with some suggesting potential indirect effects through modulation of neurotransmitter systems and neuroprotection, while others emphasize the lack of direct evidence for glucose-lowering effects in humans [2][3].

What the research actually shows

According to the research corpus, Semax demonstrates several properties that could influence glucose metabolism indirectly:

Neuroprotective Effects and Mitochondrial Stability: Semax is described as a neuroprotective agent that contributes to mitochondrial stability under stress induced by the deregulation of calcium ion flow [4].
Expression of BDNF and TrkB Receptor: Semax elevates the expression of brain-derived neurotrophic factor (BDNF) and its receptor TrkB [4].
Activation of Dopaminergic and Serotonergic Systems: Semax activates dopaminergic and serotonergic systems [4].
Antidepressant and Anxiolytic Effects: Semax can work as an antidepressant and an anxiolytic, attenuating chronic stress effects [4].
Potential Melanocortin Antagonism: Semax is a potential melanocortin antagonist, targeting receptors MC3R and MC4R [4].
Applications in Cognitive Disorders and Immune System: Semax is used to help with memory and cognitive disorders and boosts the immune system [4].
Interaction with HGF in Neurodegenerative Diseases: In the context of neurodegenerative diseases like Parkinson’s, Semax works with hepatocyte growth factor (HGF) [4].

The research corpus does not provide direct evidence that Semax lowers fasting glucose, improves insulin sensitivity, reduces HbA1c, or treats diabetes in humans [4]. Instead, it suggests that Semax’s effects on glucose metabolism are likely indirect, through its neuroprotective properties, influence on neurotransmitter systems, stress-reducing effects, and interactions with growth factors [4].

Where the AI consensus and the research diverge

The AI assistants and the research corpus agree that Semax does not have a direct, proven effect on glucose metabolism. However, the AI assistants place more emphasis on the potential for Semax to influence glucose metabolism through BDNF upregulation and melanocortin receptor activation, while the research corpus highlights a broader range of potential mechanisms, including the modulation of neurotransmitter systems and the reduction of chronic stress effects. Both sources acknowledge the lack of robust human evidence for Semax’s effects on glucose metabolism.

Bottom line: While Semax may indirectly influence glucose metabolism through various physiological effects, there is no direct evidence from the research corpus to support its use as a glucose-control agent in humans.

References

Basic and Clinical Aspects of Growth Hormone
Endocrinology_ Adult and Pediatric
GHRH, GH, and IGF-1_ Basic and Clinical Advances
GLP-1_ A New Drug for the Treatment of Type 2 Diabetes
Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
Glucose Shortens the Life Span of C elegans by — Seung-Jae Lee
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Hypothalamic Integration of Energy Metabolism
Islet Transplantation_ Clinical and Experimental
Metabolic Syndrome_ Underlying Mechanisms and Drug Therapies
Neuroanatomy of Metabolic Control
Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
Peptide Protocols Volume One — William A Seeds MD
Peptide drug discovery and development _ Translational — edited by Miguel Castanho and
Selenium_ Its Molecular Biology and Role in Human Health
The role of CNS fuel sensing in energy and glucose regulation
The role of bile acids in the pathophysiology and treatment of type 2 diabetes
Therapeutic fasting as a potential effective treatment for type 2 diabetes_ A 4-month case study
Williams Textbook of Endocrinology

Continue your research

Part of our Semax: Metabolic & Body Composition guide.

Related topics:

Continue your journey

What is the mechanism of action of Semax in modulating the hypothalamic-pituitary-adrenal axis?Semax: The Complete Peptide Guide How does Semax cross the BBB despite being a heptapeptide, and what does its actual brain pharmacokinetic curve look like when delivered intranasally vs. subcutaneously?How does Semax compare to other cognitive enhancers in terms of mechanism of action and side effects?Is Semax’s nootropic reputation in the West a translation artifact — Russian clinical practice uses it almost exclusively for stroke recovery, not cognitive enhancement in healthy adults?In what ways does Selank differ from other peptide-based anxiolytics such as Semax or Thymosin beta-4 in mechanism and clinical outcomes?

📚 The 4,000+ sources behind PeptideXR →